+499.5%
MRNA vs STT
+75.3%
+424.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | STT | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.2% | -2.4% | -2.2% |
| 7D | +5.5% | +0.5% | +5.0% | +5.8% |
| 30D | +158.7% | +3.9% | +154.9% | +157.6% |
| 3M | +182.1% | +20.0% | +162.2% | +159.5% |
| 6M | +151.8% | +55.3% | +96.5% | +98.0% |
| YTD | +393.6% | +53.3% | +340.2% | +281.7% |
| 1Y | +499.5% | +74.7% | +424.8% | +345.8% |
| All | +499.5% | +75.3% | +424.1% | +345.8% |
Cumulative growth
Daily Returns
Daily percentage return beside STT.
Daily Out/Under-Performance
Portfolio return minus STT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × STT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded STT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling